enzymatic hydrolysis comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
Commercial production usually begins with whey protein concentrate or isolate, not raw whey, to reduce fat and lactose. Food-grade proteases from bacterial or plant sources are added under controlled temperature and pH, then inactivated by heat or pH adjustment. The resulting liquid may be clarified, filtered, concentrated, and spray-dried into powder. Enzyme choice, reaction time, and pretreatment conditions create products with different peptide size distributions. Because these variables are proprietary and not standardized, two hydrolysates with the same degree of hydrolysis can differ in peptide sequences and mineral content.
Composition reflects both the original whey and the hydrolysis process. Products contain protein-derived peptides, variable ash, moisture, and residual lactose or fat depending on filtration. Some free amino acids increase during hydrolysis, and bitterness often rises with higher degrees of hydrolysis due to exposed hydrophobic residues. Mineral profiles vary with the whey source and any neutralization step. Allergenicity may be reduced in extensively hydrolyzed products, but the extent depends on residual intact protein and peptide size, and this remains a subject of ongoing study.
Whey protein hydrolysate is a dairy-derived ingredient made by treating whey protein with enzymes or acid to break peptide bonds. The starting material is typically sweet whey or acid whey from cheese manufacture, which contains beta-lactoglobulin, alpha-lactalbumin, bovine serum albumin, and immunoglobulins. Hydrolysis shortens protein chains into peptides and free amino acids, changing solubility, viscosity, and taste. The extent of breakdown is described by degree of hydrolysis, a percentage of cleaved peptide bonds. This value influences functional and sensory properties but does not by itself define a specific molecular profile.
Whey protein hydrolysate is a dairy ingredient made by breaking peptide bonds in whey proteins. Enzymes such as proteases, or in some processes acid or heat, cleave the protein chains into shorter peptides and free amino acids. The starting material may be sweet whey, acid whey, whey protein concentrate, or whey protein isolate. Because raw materials and reaction conditions differ, the final mixture is not a single uniform substance. Its peptide profile, mineral content, and residual lactose depend on the source and the processing steps used.
Production typically begins with pasteurization and concentration of whey. A protease is added under controlled temperature and pH, and the reaction is stopped by heat or pH change when the target extent of cleavage is reached. Ultrafiltration or diafiltration may remove enzymes, salts, and small molecules. The liquid is then spray dried into a powder. Process parameters shape bitterness, solubility, and peptide size. Established control points include enzyme type, reaction time, and inactivation conditions. How these variables interact across large-scale batches remains an area of active process development.
Hydrolysates usually contain 70% to 90% protein on a dry basis, with variable ash, fat, and carbohydrate. Solubility in water is generally high over a broad pH range, though bitter notes can appear from exposed hydrophobic peptides. The powder tends to absorb moisture and may brown during prolonged warm storage. Applications span sports nutrition, clinical nutrition, infant formulas, and flavor systems. Regulatory status and labeling rules differ by country. A key open question is whether a given peptide profile reliably predicts functional or sensory behavior across different food matrices.
| Property | Value | Notes |
|---|---|---|
| Appearance | Off-white to cream powder | Color varies with source and drying. |
| Solubility | High in water; pH-dependent | Shorter peptides often dissolve more readily than intact protein. |
| Typical storage temperature | 15–25 °C, dry conditions | Cool, dry storage limits moisture uptake and browning. |
| Common analytical method | Kjeldahl or Dumas for total nitrogen | Estimates protein content; not peptide size. |
| Common synonyms | Hydrolyzed whey protein; whey peptide | Hydrolysate spelling is standard in scientific use. |
Whey protein hydrolysate is a dairy ingredient made by treating whey protein concentrate or isolate with proteases that cleave peptide bonds. The resulting mixture contains shorter peptides and free amino acids than intact whey protein. Commercial products vary widely in average peptide length, residual intact protein, lactose, fat, and minerals. The term hydrolysate does not imply a single fixed composition, because enzyme choice, reaction time, pH, and temperature all shape the final peptide distribution. Products are often described by degree of hydrolysis, a percentage estimate of cleaved peptide bonds.
Production begins with pasteurized whey, which is concentrated and sometimes defatted or demineralized before hydrolysis. Food-grade proteases, such as trypsin, chymotrypsin, pepsin, or microbial enzymes, are added under controlled conditions. After a target degree of hydrolysis is reached, the enzymes are inactivated by heat or pH adjustment. The liquor is then clarified, concentrated, and dried, usually by spray drying. Ultrafiltration or diafiltration may remove residual enzymes, salts, or very small peptides, depending on the intended specification.
The peptide profile affects functional behavior more than the total protein content alone. Short peptides can be more soluble across a range of pH values and may form clearer solutions than intact whey proteins. Bitterness often rises with higher degrees of hydrolysis because certain hydrophobic peptides are exposed. Foaming, gelation, and heat stability also change as molecular size decreases. These functional shifts make hydrolysates useful in beverages, clinical nutrition, and specialty foods, though the exact relationship between peptide sequence and sensory or physical properties remains an active area of study.
Analytical testing for whey protein hydrolysate focuses on peptide size distribution, degree of hydrolysis, protein content, moisture, ash, and microbiological quality. Size-exclusion chromatography and mass spectrometry can characterize peptide profiles, while Kjeldahl or combustion methods estimate total nitrogen and protein. Amino acid analysis quantifies free and total amino acids. Because peptide mixtures are complex, no single method captures every property, and results can vary between laboratories. Standardized methods and reference materials help improve comparability, but full sequence-level characterization remains uncommon in routine quality control.
Regulatory treatment of whey protein hydrolysate depends on the country and intended use. In many jurisdictions it is regulated as a food ingredient or food for special dietary use, not as a drug. Labeling rules govern allergen statements, protein content claims, and ingredient names. Some markets have specific rules for infant formula ingredients, where hydrolysates may be used for particular dietary purposes. Regulations generally focus on safety, truthful labeling, and manufacturing standards rather than on therapeutic effects. Scientific questions about specific peptide activities remain an active area of research rather than a settled regulatory category.
Whey protein hydrolysate appears in foods, infant formula, sports nutrition, and specialized clinical nutrition. Its production can reduce viscosity and improve heat stability compared with intact whey protein. Bitterness is common because short hydrophobic peptides can activate bitter taste receptors. The ingredient is not the same as free amino acids; it remains a mixture of peptides of different lengths. Composition varies by supplier, enzyme, and process, so two hydrolysates with the same protein content may behave differently in a formulation.
Whey protein hydrolysate is a dairy ingredient made by treating whey protein with enzymes or, less often, acid or heat to break peptide bonds. The starting material is typically sweet whey or acid whey from cheese making, first concentrated and dried into whey protein concentrate or isolate. Hydrolysis shortens long protein chains into smaller peptides, changing functional properties such as solubility, viscosity, and foam formation. The resulting powder contains peptides, residual intact protein, moisture, minerals, and variable amounts of lactose and fat depending on the starting material.
Enzymatic hydrolysis usually uses proteases from microbial, plant, or animal sources. The enzyme choice, pH, temperature, and reaction time determine which peptide bonds are cleaved and the final peptide profile. After hydrolysis, the enzyme is inactivated by heat, and the mixture is clarified, filtered, concentrated, and spray-dried. Manufacturers may use ultrafiltration to remove larger peptides or minerals. The degree of hydrolysis, often reported as a percentage, describes the proportion of peptide bonds broken. A higher degree generally means shorter peptides, but it does not by itself define taste, allergenicity, or biological activity.
Ants perform many ecological roles that are beneficial to humans, including the suppression of pest populations and aeration of the soil. It has been estimated that an average of about 1.5 tons of subsoil are moved to the surface (bioturbation) by ants per year per hectare. The use of weaver ants in citrus cultivation in southern China is considered one of the oldest known applications of biological control. On the other hand, ants may become nuisances when they invade buildings or cause economic losses. About nineteen species have been considered as "invasives" by the IUCN including Linepithema humile, Solenopsis invicta, Pheidole megacephala, Wasmannia auropunctata, and Anoplolepis gracilipes. In some parts of the world (mainly Africa and South America), large ants, especially army ants, are used as surgical sutures. The wound is pressed together and ants are applied along it. The ant seizes the edges of the wound in its mandibles and locks in place. The body is then cut off and the head and mandibles remain in place to close the wound. The large heads of the dinergates (soldiers) of the leafcutting ant Atta cephalotes are also used by native surgeons in closing wounds. Some ants have toxic venom and are of medical importance. The species include Paraponera clavata (tocandira) and Dinoponera spp. (false tocandiras) of South America and the Myrmecia ants of Australia. In South Africa, ants are used to help harvest the seeds of rooibos (Aspalathus linearis), a plant used to make a herbal tea. The plant disperses its seeds widely, making manual collection difficult.
== Examples of CGRP inhibitors == Small molecule CGRP antagonists are generally administered by mouth as pills. One type is a nasal spray. In contrast, CGRP monoclonal antibodies involve large molecules which must be given intravenously or as injections. Injections can be self-administered with an automatic pen monthly or quarterly, depending on the drug.
Some mammalian species and subspecies of Portugal such as red deer, Iberian ibex, wild boar, red fox, Iberian wolf, and Iberian lynx were once widespread throughout the country, but intense hunting, habitat degradation, and growing pressure from agriculture and livestock largely reduced their populations in the 19th and 20th centuries. There are three mammalian species and subspecies, such as the Portuguese ibex that became extinct, but some mammalian species, such as the Iberian hare, have been re-expanding their native range.
Sources: en.wikipedia.org
Nor are rights of pre-emption to buy shares, nor rights of any party regarding claims by tort, contract or piercing the corporate veil to hold directors and shareholders accountable. However, Directives do require minimum rights on company formation, capital maintenance, accounting and audit, market regulation, board neutrality in a takeover bid, rules on mergers, and management of cross-border insolvency. The omission of minimum standards is important since the Court of Justice held in Centros that freedom of establishment requires companies operate in any member state they choose. This has been argued to risk a "race to the bottom" in standards, although the Court of Justice soon affirmed in Inspire Art that companies must still comply with proportionate requirements that are in the "public interest".
After assuming the presidency, Lula made his first international trip as president to Buenos Aires, where he announced that Brazil would resume its relations with Latin America and that the government would be willing to finance infrastructure works in neighbouring countries through the BNDES again. Lula also defended the construction of a gas pipeline between Brazil and Argentina to transport the shale gas extracted in the Vaca Muerta field. The idea was criticized by some experts, as the project may cause damage to the region's environment. The announcement also generated several criticisms from economists, as this practice has already caused the country to suffer from defaults in the past. In May 2023, Lula and Argentine president Alberto Fernández – a Peronist and Lula ally who while still a candidate had visited Lula in prison – in Brasília to discuss the economic crisis in Argentina as well as trade and energy between Argentina and Brazil. Lula stated that he has committed to make "each and every sacrifice so we can help Argentina in those hard times" including reaching out to both the IMF and the BRICS and that he will back up Brazilian exporters operating in the country. Lula welcomed Fernández in Brasília in June 2023 to celebrate the 200th anniversary of the establishment of diplomatic relations between Brazil and Argentina during which Fernández was rewarded with Brazil's highest award the Order of the Southern Cross.
=== No development reported === AD-6626 – aldehyde dehydrogenase 2 (ALDH2) inhibitor – alcoholism AM-6527 (AM6527) – cannabinoid CB1 receptor antagonist – substance-related disorders Amitifadine (DOV-21947; EB-1010) – serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI) – alcoholism, opioid-related disorders, smoking withdrawal, substance-related disorders Arbaclofen extended release – GABAB receptor agonist – opioid-related disorders BMB-101 – serotonin 5-HT2 receptor agonist – opioid-related disorders Bupropion/mecamylamine (INT-0003; QuitPak) – combination of bupropion (norepinephrine–dopamine reuptake inhibitor (NDRI), nicotinic acetylcholine receptor negative allosteric modulator) and mecamylamine (non-selective nicotinic acetylcholine receptor antagonist) – smoking withdrawal Cannabidiol (CBD; cannabidiol transderma/topical gel/patch; Zygel; ZYN-002) – cannabinoid/various actions – alcoholism, substance-related disorders CM-1212 – undefined mechanism of action – alcoholism, substance-related disorders CPP-115 – GABA transaminase (GABA-T) inhibitor – substance-related disorders CT-044 analogues - CERSCI Therapeutics – reactive oxygen species (ROS) inhibitors (CT-044 analogues) – opioid-related disorders CX-717 (CX717) – AMPA receptor positive allosteric modulator (ampakine) – substance-related disorders Cyproheptadine/prazosin (KT-110; Periactine/Alpress) – combination of cyproheptadine (various actions) and prazosin (α1-adrenergic receptor antagonist) – substance-related disorders DCR-AUD (DCR-A1203; NN-6020) – aldehyde dehydrogenase 2 (ALDH2) inhibitor, RNA interference – alcoholism Dimethyltryptamine (DMT; EBRX-101) – non-selective serotonin receptor agonist, serotonin 5-HT2A receptor agonist, and serotonergic psychedelic – smoking withdrawal GLWL-01 – ghrelin O-acyltransferase (GOAT) inhibitor – alcoholism GSK-598809 (GSK598809) – dopamine D3 receptor antagonist – smoking withdrawal, substance-related disorders GSK-1521498 – μ-opioid receptor inverse agonist – cocaine-related disorders GTS-21 (DMXB-A; DMBX-anabaseine) – nicotinic acetylcholine receptor agonist – smoking withdrawal Icalcaprant (ABBV-1354; CVL-354) – κ-opioid receptor antagonist – substance-related disorders Levodopa (CVT-301; CXG-89; Inbrija) – dopamine precursor (non-selective dopamine receptor agonist) – smoking withdrawal Mazindol controlled release (NLS-0; NLS-1; NLS-10; NLS-13; NLS-2; Nolazol; Quilience) – serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI) – opioid-related disorders Midomafetamine (MDMA; ecstasy) – serotonin–norepinephrine–dopamine releasing agent (SNDRA), serotonin 5-HT2 receptor agonist, and entactogen – substance-related disorders Mifepristone (C-1073; Corlux; Corluxin; Korlym; Mifegyne; Mifeprex; RU-38486; RU-486) – glucocorticoid, progesterone, and androgen receptor antagonist – smoking withdrawal Modafinil oral (ASB) – atypical dopamine reuptake inhibitor (DRI) – cocaine-related disorders Naloxone nasal spray (-12; LT-20; LT-21; LT-22; Naloxon B; Narcan Nasal Spray; OPNT-001) – μ-opioid receptor antagonist – cocaine-related disorders, substance-related disorders Nalmefene implant (nalmefene six-month implant) – μ-opioid receptor antagonist, κ-opioid receptor weak partial agonist – opioid-related disorders Naloxone buccal/intransal gel (Exonal) – opioid receptor antagonist – opioid-related disorders Nicotine abuse vaccine (Niccine) – nicotinic acetylcholine receptor agonist – smoking withdrawal Nicotine/cannabidiol chewing gum (nicotine/CBD; CVSI-007) – combination of nicotine (nicotinic acetylcholine receptor agonist) and cannabidiol (CBD) (cannabinoid/various actions) – smoking withdrawal Noribogaine derived therapeutic – various actions (noribogaine derivative) – opioid-related disorders OMS-405 (OMS405) – PPARγ agonist – alcoholism Ondansetron (AD-04) – serotonin 5-HT3 receptor antagonist – opioid-related disorders, smoking withdrawal Ondansetron/topiramate (AD-01; AD/TO-01) – combination of ondansetron (serotonin 5-HT3 receptor antagonist) and topiramate (various actions) – alcoholism Ondelopran (LY-2196044; Odelepan; Odelepran; OpRA) – opioid receptor antagonist – alcoholism OPNT-005 (OPNT005; adjuvanted heroin analogue vaccine; diamorphine analogue vaccine; heroin vaccine) – immunostimulant (vaccine against heroin) – heroin-related disorders PF-5402536 (NIC7-001; PF-5402536) – immunostimulant (smoking vaccine) – smoking withdrawal Pomaglumetad methionil (DB103; LY-2140023; LY-2812223; LY-404039 prodrug) – metabotropic glutamate mGlu2 and mGlu3 receptor receptor agonist (pomaglumetad prodrug) – substance-related disorders PPL-103 – μ-opioid receptor agonist, δ-opioid receptor agonist, κ-opioid receptor agonist – substance-related disorders Pregnenolone methyl ether (3β-methoxypregnenolone; MAP-4343) – microtubule-associated protein (MAP) stimulant and tubulin polymerization promoter – substance-related disorders Psilocybin (MYCO-001; MYCO-003) – non-selective serotonin receptor agonist, serotonin 5-HT2A receptor agonist, and serotonergic psychedelic – substance-related disorders PT-150 (PT150; ORG-34517; SCH-900636) – androgen and glucocorticoid receptor antagonist – alcoholism Research programme: alcoholism therapeutics - ADial Pharmaceuticals – various actions – alcoholism Research programme: allosteric modulators - Addex Therapeutics – various actions – substance-related disorders Research programme: GPCR modulators - Nxera Pharma – various actions – cocaine-related disorders, substance-related disorders Research programme: nociceptin receptor agonists - Astraea Therapeutics – nociceptin receptor agonist, opioid receptor agonist – alcoholism, substance-related disorders Research programme: smoking cessation therapies - Ophidion – smoking withdrawal – nicotinic acetylcholine receptor agonists Research programme: tryptamine based therapeutics - PsyBio Therapeutics – serotonin 5-HT2A receptor agonists – substance-related disorders RTI-598929 – μ-opioid receptor antagonist and κ-opioid receptor antagonist – heroin-related disorders Saracatinib (AZD-0530) – Src-family kinase inhibitor – alcoholism SBP-9330 – metabotropic glutamate mGlu2 receptor modulator – smoking withdrawal SEL-068 (tSVP; immunomodulatory nanoparticle vaccine for smoking cessation) – immunomodulator (smoking vaccine) – smoking withdrawal Serdexmethylphenidate (KP-484; KP-1077; KP-1077H; KP-1077IH; KP-1077N; KP-879) – norepinephrine–dopamine reuptake inhibitor (NDRI) (dexmethylphenidate prodrug) – substance-related disorders TRV-734 (TRV734) – μ-opioid receptor biased agonist – opioid-related disorders VDM-001 – opioid receptor antagonist – alcoholism, opioid-related disorders Zolunicant (18-methoxycoronaridine; 18-MC; MM-110) – α3β4 nicotinic acetylcholine receptor antagonist – substance-related disorders
Sources: en.wikipedia.org
. Thus, the rule of conservation of energy over time in special relativity continues to hold, so long as the reference frame of the observer is unchanged. This applies to the total energy of systems, although different observers disagree as to the energy value. Also conserved, and invariant to all observers, is the invariant mass, which is the minimal system mass and energy that can be seen by any observer, and which is defined by the energy–momentum relation.
In Santa Maria, Azores, dill (endro) is the most important ingredient of the traditional Holy Ghost soup (sopa do Espírito Santo). Dill is found ubiquitously in Santa Maria, yet, is rare in the other Azorean Islands. In Sweden, dill is a common spice or herb. The flowers of fully grown dill are called 'krondill' (crown dill) and used when cooking crayfish. Krondill is also used to flavor pickles and vodka. The thinner part of dill and young plants may be used with boiled fresh potatoes. In salads it is used together with, or instead, of other green herbs, such as parsley, chives, and basil. It is often paired with chives. Dill is often used to flavour fish and seafood in Sweden, for example, gravlax and various herring pickles, among them the traditional 'sill i dill' (literally 'herring in dill'). There is also a traditional Swedish dish called 'dillkött', which is a meaty stew flavoured with dill, commonly served as a vinegary sauce. Dill seeds may be used in breads or 'akvavit'. A newer use of dill is to pair it with chives as a flavouring for potato chips. These are called 'dillchips'. In Finland, the uses of dill are very similar to those in Sweden, including flavouring potato chips and, less popularly, in a dish similar to 'dillkött' ('tilliliha'). However, the use of dill in Finland is not as extensive as in large parts of central and eastern Europe, particularly Russia but including even the ethnolinguistically close Estonia.
The set of subjects that is as close as possible to the ideal implied by the intention-to- treat principle. It is derived from the set of all randomised subjects by minimal and justified elimination of subjects. (ICH E9)
==== Carbohydrates ==== The principal soluble carbohydrates of mature soybeans are the disaccharide sucrose (range 2.5–8.2%), the trisaccharide raffinose (0.1–1.0%) composed of one sucrose molecule connected to one molecule of galactose, and the tetrasaccharide stachyose (1.4 to 4.1%) composed of one sucrose connected to two molecules of galactose. While the oligosaccharides raffinose and stachyose protect the viability of the soybean seed from desiccation (see above section on physical characteristics) they are not digestible sugars, so contribute to flatulence and abdominal discomfort in humans and other monogastric animals, comparable to the disaccharide trehalose. Undigested oligosaccharides are broken down in the intestine by native microbes, producing gases such as carbon dioxide, hydrogen, and methane. Since soluble soy carbohydrates are found in the whey and are broken down during fermentation, soy concentrate, soy protein isolates, tofu, soy sauce, and sprouted soybeans are without flatus activity. On the other hand, there may be some beneficial effects to ingesting oligosaccharides such as raffinose and stachyose, namely, encouraging indigenous bifidobacteria in the colon against putrefactive bacteria. The insoluble carbohydrates in soybeans consist of the complex polysaccharides cellulose, hemicellulose, and pectin. The majority of soybean carbohydrates can be classed as belonging to dietary fiber.
Sources: en.wikipedia.org
It is whey protein that has been broken into smaller peptides and amino acids through enzymatic or acid hydrolysis. The resulting ingredient is used in food and nutritional products for its altered functional and sensory properties. It is not a single uniform substance because production conditions vary.
Hydrolysis targets peptide bonds, not lactose, so the lactose content depends mainly on the starting whey protein concentrate or isolate. Filtration steps before or after hydrolysis can reduce lactose. A hydrolysate labeled as isolate typically contains less lactose than one derived from concentrate.
No. Whey isolate refers to a high-protein, low-fat, low-lactose whey fraction, while hydrolysate refers to protein that has been cleaved into smaller peptides. A product can be both whey isolate and hydrolyzed. The terms describe different processing dimensions.
Hydrolysis extent indicates the share of peptide bonds that have been cleaved. It is often estimated from free amino groups and is reported as a percentage. A higher value means smaller peptides and more free amino acids, but it does not by itself define product quality.